Retrovirus-mediated stem cell reprogramming introduces pluripotency genes into somatic cells via integrating viral vectors. This method ensures stable iPSC generation and long-term gene expression, supporting developmental biology and disease modeling, though it carries risks of insertional mutagenesis unsuitable for clinical applications.
